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Critically ill post-surgical, post-trauma and/or septic patients are characterised by severe inflammation. This immune
response consists of both a pro- and an anti-inflammatory component. The pro-inflammatory component
contributes to (multiple) organ failure whereas occurrence of immune paralysis predisposes to infections.
Strikingly, infectious complications arise in these patients despite the presence of a clear neutrophilia. We
propose that dysfunction of neutrophils potentially increases the susceptibility to infections or can result in the
inability to clear existing infections. Under homeostatic conditions these effector cells of the innate immune
system circulate in a quiescent state and serve as the first line of defence against invading pathogens. In severe
inflammation, however, neutrophils are rapidly activated, which affects their functional capacities, such as chemotaxis,
phagocytosis, intra-cellular killing, NETosis, and their capacity to modulate adaptive immunity. This review provides an
overview of the current understanding of neutrophil dysfunction in severe inflammation. We will discuss the possible
mechanisms of downregulation of anti-microbial function, suppression of adaptive immunity by neutrophils and the
contribution of neutrophil subsets to immune paralysis.Background
Severe inflammation induced by trauma, sepsis or ische-
mia/reperfusion injury is known to contribute to devas-
tating complications such as acute respiratory distress
syndrome (ARDS) and (multiple) organ failure [1]. This
has been attributed to microvascular dysfunction, tissue
damage and dysregulation of metabolism caused by
severe inflammation [2]. In recent years, however, it
has been recognised that severe systemic inflammation
can also result in a profound ‘compensatory’ down-
regulation of immune responses, rendering the host
susceptible to infections or unable to clear existing in-
fections [3]. Although conceivably an evolutionarily
preserved response to protect the host from immune-
mediated tissue damage, downregulation of anti-
microbial immunity creates an unwanted consequence:
susceptibility to bacterial infections such as caused by
Staphylococcus aureus, Pseudomonas aeruginosa and
Escherichia coli as well as opportunistic fungal infections* Correspondence: plelief2@umcutrecht.nl
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activation of viruses such as cytomegalovirus are found in
critically ill patients [7]. These findings clearly indicate
that both the innate and the adaptive immune system are
dysfunctional in these patients. Nosocomial infections in
critically ill patients are associated with an increased
length of hospital stay, increased health care costs and
profound additional morbidity and mortality [8].
Neutrophils, effector cells of the innate immune
system, are abundantly present in the circulation and
comprise up to 50–70 % of total circulating leukocytes
in humans. The enhanced frequency and severity of bac-
terial and fungal infections in patients with congenital
neutrophil disorders demonstrate that neutrophils are
indispensable for adequate protection against microbes
[9]. Patients suffering from leucocyte adhesion deficiency
(LAD)-I are at risk for development of necrotizing infec-
tions and sepsis because of inadequate neutrophil trans-
endothelial migration to the site of infection [10]. The
Chediak-Higashi syndrome and chronic granulomatous
disease (CGD) underscore the eminent importance of
intracellular bacterial killing by neutrophils. Chediak-
Higashi syndrome is caused by a mutation in the LYST
gene, which encodes a lysosomal trafficking regulator
[11]. The mutation leads to the absence of a properle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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Chediak-Higashi are extremely susceptible to pyogenic
infections and this syndrome is usually fatal before the
age of 10 [11]. CGD is characterised by a defect in pro-
duction of the bactericidal reactive oxygen species (ROS)
due to defective NADPH oxidase and results in recur-
rent infections, reducing life-expectancy significantly
[12]. In murine models of sepsis, knockout of essential
neutrophil antimicrobial functions leads to rapid death.
For instance, mice lacking the neutrophil granule pro-
teins myeloperoxidase or elastase die more rapidly from
sepsis [13, 14]. Apart from the severe phenotypes seen
in patients with inborn errors and murine knockout
models, more subtle effects were seen in a murine sepsis
model where rapid death coincided with inadequate
phagosomal acidification of neutrophils after phagocyt-
osis [15]. These studies highlight the generally accepted
importance of neutrophils in antimicrobial defence in
acute inflammatory models. In addition, they demon-
strate disturbances in the anti-microbial functionality of
these cells during severe inflammation.
In this review we will discuss neutrophil functions
required for adequate microbial defence and the
mechanisms leading to neutrophil-mediated immune
dysfunction.
Functions of neutrophils associated with
anti-microbial defence
Chemotaxis
The controlled process of phagocytosis and killing of mi-
crobes by neutrophils firstly requires chemotaxis to-
wards the site of infection. Chemotaxis is the propensity
of cells to migrate in the direction of gradients of
chemotactic stimuli [16]. The ability to adequately sense
chemotactic gradients is one of the final capabilities ac-
quired by neutrophils during maturation in the bone
marrow and this functionality appears to be the most
sensitive to perturbations in vivo and in vitro [17]. Im-
pairment of chemotaxis has been described in a wide
variety of diseases associated with increased susceptibil-
ity to infections: diabetes mellitus, viral infections
(influenza), cytomegalovirus, HIV and tropical diseases
(malaria) [18–22]. In sepsis, chemotaxis of neutrophils is
impaired through various mechanisms [23–25]. Interleu-
kin (IL)-33 limits this impairment by preventing down-
regulation of CXCR2 and improves outcome in a murine
model [26]. In humans, extensive research has focused
on the chemotactic capacity of neutrophils from burn
patients. It has been shown that neutrophils from ther-
mally injured subjects are characterised by impaired
chemotaxis, both in vivo in the tissue and in vitro, to-
wards the bacterial peptide fMLF, which is believed to
contribute to the increased susceptibility to infections in
this group of patients [27, 28].Intracellular killing
Once neutrophils have found and recognised a pathogen,
phagocytosis can take place and subsequent bacterial
killing occurs in the phagolysosome. Neutrophils possess
two separate but intercalating anti-microbial mecha-
nisms, one dependent on oxygen and the other
independent of it. Although categorisation of killing
mechanisms in this manner creates a comprehensive un-
derstanding, it does not reflect the in vivo situation in
which both systems operate simultaneously. Further-
more, it is likely that the individual significance of both
killing mechanisms shifts during the course of inflam-
mation. This is due to fluxes in oxygen demand and sup-
ply caused by dynamic tissue perfusion and oxygenation
during the inflammatory response [29].
The oxygen-dependent mechanisms are mediated by
ROS downstream of O2
− formed by the NADPH oxidase
complex [30]. In short, upon activation of a neutrophil,
either via ingestion of bacteria or by extracellular stim-
uli, the NADPH oxidase complex is assembled from
both cytosolic and membrane-bound components [31].
The active oxidase complex transports electrons from
cytosolic NADPH across the membrane to the electron
acceptor, molecular oxygen, generating superoxide anion
[29]. This is in turn metabolises in the phagosome into
highly bactericidal end products, such as hydroxyl rad-
ical, hydrogen peroxide and hypochlorous acid [31]. In
sterile inflammation, such as trauma or acute liver
failure, neutrophils are known to produce elevated levels
of spontaneous ROS [32, 33]. Furthermore, ROS produc-
tion in these patients in response to a stimulus is
strongly elevated in comparison with that found in neu-
trophils from healthy controls; a process generally re-
ferred to as priming [27, 34–36]. Uncontrolled release of
ROS by neutrophils accumulating in vascular beds can
contribute to loss of endothelial barrier integrity and
subsequent vascular leakage, predisposing patients to
organ injury as a result of pro-inflammatory complica-
tions (acute lung injury, ARDS) [37, 38]. This hypothesis
is in line with the findings of increased ROS production
in trauma patients developing ARDS in comparison with
control trauma patients [39]. In addition, the observa-
tion that neutrophils from patients with fatal sepsis are
characterised by markedly increased production of ROS
compared with survivors is noteworthy [40].
Granule products comprise the backbone of non-
oxidative killing by neutrophils [41]. The azurophilic
granule is a reservoir of serine proteases: neutrophil
elastase, cathepsin G, proteinase 3, and azurocidin [42].
These digestive proteases are delivered into the phagoly-
sosome upon fusion of granules with a phagosome
containing bacteria. During maturation of the phagolyso-
some the intraphagosomal pH is rigorously altered. The
early shift of intraphagosomal pH towards an alkaline
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− provides
the initial milieu for the proper activation of proteases,
leading to optimal microbicidal and digestive function of
these enzymes [43]. Concomitant with the waning of
production of ROS the phagosome progressively acid-
ifies, coinciding with granule–phagosome fusion. These
granules contain the Na+/H+-antiporter V-ATP-ase,
which is responsible for pumping of protons into the
phagosome [44–46]. Neutrophils of burn-injured pa-
tients are characterised by dysfunctional pH control of
their phagolysosomes since these patients fail to demon-
strate transient phagosomal alkalinisation in the first
5 minutes and acidify promptly after ingestion of bac-
teria [47]. This situation might lead to improper acti-
vation of the proteases and impaired killing of
ingested microbes. On the other hand, deficient acid-
ification of peritoneal neutrophils in a murine model
of sepsis was associated with increased mortality [15].
These findings demonstrate the importance of ad-
equate intraphagosomal pH regulation for microbial
control.
The presence and proper function of granules intracel-
lulary are crucial as these organelles supply neutrophils
with an arsenal of antimicrobial mechanisms. However,
uncontrolled activation of neutrophils in an inflamma-
tory microenvironment can lead to collateral tissue dam-
age by excessive extracellular degranulation and the
release of neutrophil proteases. Neutrophil extravasation,
homing and activation are mediated by activation of
several surface receptors, including β2 integrins, comple-
ment receptors, Fcγ-receptors, and formyl peptide
receptors. Uncontrolled activation of neutrophils is me-
diated through these same receptors by responding to
aberrant production of chemokines, cytokines and re-
lease of extracellular peptides [48]. During this process
granules fuse with the plasma membrane, releasing their
content into the environment [49]. More tissue damage
will lead to increased influx and activation of neutro-
phils, which then leads to a vicious cycle of tissue
destruction [50].
Neutrophil extracellular traps
In addition to conventional intracellular killing and deg-
radation of individual bacteria, the concept of extracellu-
lar killing by neutrophils using neutrophil extracellular
traps (NETs) has received much attention during the
past decade [51, 52]. NETs consist of fibrils formed by
active expulsion of DNA, chromatin and granule pro-
teins from neutrophils [52, 53]. They are formed in re-
sponse to a variety of pro-inflammatory stimuli of which
IL-8, tumour necrosis factor-alpha and lipopolysacchar-
ide are the most relevant [54]. During formation of
NETs neutrophils die and this process is generally re-
ferred to as NETosis. This form of cell death isdependent on the NADPH-oxidase complex since neu-
trophils treated with the pharmacological NADPH-
oxidase inhibitor DPI and CGD patients are unable to
release NETs [53]. In vitro NETs were shown to be a
cell-death-associated event occurring hours after stimu-
lation [53]. However, intravital microscopy revealed
viable neutrophils after formation of NETs and the
resulting anuclear neutrophils were subsequently capable
of phagocytosis and formation of mature phagosomes.
These data indicate that NETosis does not necessarily
result in cell death [55]. The direct bactericidal proper-
ties of NETs are a topic of discussion, and prevention of
bacterial dissemination in vivo might be their main func-
tion [56]. Apart from this antimicrobial function, the
cytotoxicity of NETs can be harmful to the host if their
release is inappropriately controlled. NETs are released
following sepsis, trauma and ischemia–reperfusion injury
and a growing body of evidence shows they can contrib-
ute to tissue destruction, as reviewed by Liu et al. [57].
The potential of NETs to cause tissue destruction was
elegantly demonstrated in a murine model of primary
graft-dysfunction after lung transplantation [58]. In
addition, several studies argue that NETs might be in-
volved in triggering auto-immune diseases since auto-
antibodies against NET constituents (e.g. DNA) are often
found in these diseases [59, 60]. Although NETs have
firmly established their tissue-damaging properties, scep-
ticism still exists about the in vivo anti-microbial rele-
vance of NETs [61].
Neutrophil dysfunction in acute inflammation
The mechanisms involved in adequate anti-microbial de-
fence can also disrupt subsequent immunity. This is
caused by aberrant control of their own essential anti-
microbial arsenal, such as: (1) auto- and paracrine cleav-
age of essential surface receptors; (2) downregulation of
surface receptors and signalling pathways in non-
resolving inflammation or during a second microbial hit
following initial sterile inflammation (damage-associated
molecular pattern (DAMP)–microbe-associated molecu-
lar pattern (MAMP) interference); and (3) the release
of neutrophil populations with decreased microbicidal
properties. In addition, neutrophils in inflammatory
conditions can affect other immune cells and contrib-
ute to immune paralysis of the adaptive immune
system.
Proteolytic cleavage by neutrophil-derived proteases and
downregulation of immune receptors
Serine proteases released by neutrophils influence the
expression of receptors critical to neutrophil–microbial
interactions (Fig. 1a). Apart from stimulatory effects
through serine protease activated receptors (PARs),
they can downregulate immune responses by cleaving
AB
Fig. 1 Downregulation of immune receptors by serine proteases from degranulated neutrophils and desensitisation by pattern recognition
receptors. a Schematic representation of downregulation of receptors on neutrophils, monocytes and lymphocytes during inflammation due to
cleavage by neutrophil serine proteases after degranulation. Binding of C5a to neutrophils results in internalisation of C5aR. Decreased expression
of these receptors impairs neutrophil effector functions during subsequent challenges. b Biological mimicry between DAMPs and MAMPs.
Danger signals derived from necrotic tissue cells ("First hit") bind to pattern recognition receptors (PRRs) and limit subsequent responses
to microbial signals ("Second hit") through homo- and heterologous desensitisation. DAMP damage-associated molecular pattern, IL interleukin,
MAMP microbe-associated molecular pattern
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and innate immune cells [62]. For instance, neutro-
phil elastase cleaves CXCR1, a receptor for IL-8, on
the surface of neutrophils [63, 64]. This mechanism is
relevant during acute inflammation in which circulating
neutrophils from trauma and sepsis patients selectively
downregulate CXCR2, the only other neutrophil receptor
for IL-8 [65, 66]. Tarlowe et al. [67] provided evidence that
downregulation of this receptor preceded the occurrence
of pneumonia in critically ill trauma patients. Downregu-
lation of CXCR2 and cleavage of CXCR1 would result in
severe hyporesponsiveness to IL-8, an important neutro-
phil chemoattractant.
Furthermore, neutrophil serine proteases can cleave
complement receptors such as the CR1 receptor (CD35)
and C5aR (CD88) on neutrophils [68, 69]. These receptorsare important as they mediate chemotaxis, degranulation
and proper recognition of opsonised microbial targets by
CR1 and C5aR, respectively [70]. During inflammation,
decreased expression of C5aR is seen due to engagement
and subsequent internalisation. This can result in a pro-
found defect in neutrophil phagocytosis of subsequent
pathogens as C5a-induced chemotaxis is important for
neutrophils to find opsonised targets [71]. Proteases not
only inhibit the function of neutrophils, they can also
affect monocytes in the micro-environment. Neutrophil
elastase cleaves CD14, a receptor necessary for the high
affinity recognition of lipopolysaccharide by TLR4,
thereby impairing proper bacterial recognition by
monocytes [72]. Lastly, elastase and cathepsin G medi-
ate shedding of cytokine receptors for IL-2 and IL-6
on T lymphocytes [73].
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Trauma and ischemia/reperfusion injury can evoke the
release of large amounts of cellular components from
necrotic cells. These intracellular constituents are known
as damage-associated molecular patterns (DAMPS).
They are host-derived and serve as important pro-
inflammatory non-microbial stimuli after injury [74].
Since the development of the ‘danger hypothesis’ by
Matzinger [74], a large number of studies have focussed
on molecules driving this response. The most extensively
studied DAMPS are high-mobility group box 1, heat
shock proteins, ATP, uric acid, formylated peptides from
mitchondria and mitochondrial DNA [75–80]. Inflam-
mation induced by pathogens on the other hand is
mediated through microbial constituents referred to as
microbe-associated molecular patterns (MAMPS), which
resemble DAMPS and, importantly, share similar pattern
recognition receptors (PRRs) on the neutrophil [81].
This biological mimicry and utilisation of similar recep-
tors creates a problem for the immune system since in-
jury (DAMPS) causes downregulation of many of these
receptors by hetero- and homologous desensitisation.
This can render neutrophils unable to mount an ad-
equate response to a subsequent microbe (MAMP)
(Fig. 1b). To illustrate the relevance of this phenomenon,
Zhang et al. [80] showed the release of vast amounts of
mitochondrial formylpeptides into the circulation of
major trauma patients. These molecules stimulate neu-
trophils via formyl peptide receptor 1 (FPR1), an import-
ant receptor in recognizing microbes that produce
danger signals by release of formyl-peptides [80] (Fig. 1b).
It was shown that heterologous desensitisation of che-
mokine receptors and homologous desensitisation of
FPR1 occurred simultaneously, predisposing trauma pa-
tients to infection [82].
Release of incompetent neutrophil populations
Much of the work detailed in the previous sections did
not take into account the variations in functional pheno-
types that appear in the circulating neutrophil compart-
ment during severe inflammation. After maturation
neutrophils are retained in the bone marrow via expres-
sion of chemokine receptor CXCR4 (ligand CXCL12),
whilst CXCR2 (ligands IL-8/CXCL1 and 2) controls re-
lease into the peripheral blood. Inflammatory stimuli
can induce the release of neutrophils by disrupting the
balance in CXCR4/CXCL12 signalling through various
mechanisms [60]. In severe inflammation large numbers
of neutrophils are released into the circulation from the
bone marrow post-mitotic pool as well as from the mar-
ginated pool (i.e. neutrophils not freely circulating but
attached to the microvasculature) [83]. Under these con-
ditions we have previously shown that peripheral neutro-
phils consist of heterogeneous subsets with differentpriming states and function [84]. During severe inflam-
mation a large number of immature or banded cells ap-
pear in the circulation and even neutrophil progenitor
cells can be identified. As a result, persistent severe in-
flammation might lead to "bone marrow exhaustion" of
neutrophils, which is thought to inevitably result in a
state of compromised innate immunity [85]. At present,
however, it is unclear how to interpret the presence of
immature cells in the bloodstream in response to inflam-
mation. It might be a compensatory response initiated
by the depletion of mature neutrophils in the bone mar-
row or a dedicated inflammatory reaction to a bacterial
stimulus. Our data support the first hypothesis since
these immature neutrophils also show a pronounced de-
crease of various receptors in comparison with their
mature circulating counterparts [84]. In addition to the
IL-8 receptors (CXCR1 and CXCR2) and the C5a recep-
tor, the Fc receptors (CD16 and CD32), which are
important in pathogen recognition, phagocytosis and
killing, are also downregulated on immature cells (Fig. 2)
[84]. Relatively few studies have assessed the functional-
ity of immature and progenitor neutrophils subsets in
severe human inflammation. In septic patients, imma-
ture neutrophils were shown to have decreased
phagocytic capacity [86]. Importantly, reduced phago-
cytosis and increased numbers of circulating neutro-
phil progenitors are both associated with poor outcome
in septic patients as well as in patients with severe in-
flammation [87, 88].
Suppression of adaptive immunity by neutrophils
Neutrophils have long been recognised as professional
killers. Eradication of bacteria and fungi was thought to
be their main task. Evidence is, however, accumulating
that apart from their direct anti-microbial function,
neutrophils participate in subsequent modulation of
(adaptive) immune responses in severe inflammation
[89–91]. Under these inflammatory conditions, neutro-
phils produce chemokines and secrete granule contents
which can subsequently attract and modulate the func-
tion(s) of T cells both directly and indirectly [92, 93].
For instance, neutrophil elastase reduces expression of
co-stimulatory molecules by dendritic cells, limiting
maturation and induction of a proper Th1 response [94].
In addition, T cells in the inflammatory microenviron-
ment may be affected by neutrophil elastase by cleavage
of their IL-2 and IL-6 receptors (Fig. 1a) [95]. Another
mechanism of immune-modulation was observed in
macrophages after phagocytosis of apoptotic neutrophils.
Under these conditions immune responses of macro-
phages shift towards a more anti-inflammatory cytokine
profile [96]. Furthermore, neutrophils themselves have
been shown to produce anti-inflammatory cytokines
such as IL-1ra and IL-10 [97]. However, the evidence
Fig. 2 Circulating neutrophil subsets in severe inflammation. At least four types of neutrophils circulate in the bloodstream of patients during
severe inflammation: immature, competent and suppressive neutrophils and myeloid-derived suppressor cells. Mechanisms contributing to
immune dysfunction are displayed for neutrophils from different subsets. ROS reactive oxygen species
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sial, as it has only been shown in mice with mycobacter-
ial infections [98]. In humans neutrophils are unable to
produce IL-10 [99]. Direct regulation of T-cell responses
by neutrophils is slowly becoming an established con-
cept. A large body of evidence demonstrates that a het-
erogeneous group of immature mononuclear cells and
neutrophils termed myeloid-derived suppressor cells
(MDSCs) can suppress T-cell responses in several mur-
ine tumour models. In addition, these cells have been
shown to play a role in various models of infectious dis-
eases, organ transplantation and autoimmune diseases
[100]. Identification of human immature granulocytic
MDSCs has proven to be challenging though. In particu-
lar, their differentiation from mature neutrophil pheno-
types seen in the blood during acute inflammation
remains to be established, as we have reviewed in detail
elsewhere [101]. The mechanisms by which MDSCs can
suppress T cells include the expression and secretion of
arginase-1, which depletes arginine from the microenvir-
onment (Fig. 2) [102]. Depletion of L-arginine, which is
an essential amino acid, results in cell cycle arrest of T
cells in the G0–G1 phase [103]. Furthermore, in human
inflammation we and others have observed a population
of mature CD62Ldim neutrophils capable of suppressing
T-cell responses through a mechanism which relies on
ROS release in an immunological synapse [104]. Re-
cently, similar neutrophils in septic shock patients have
been found to express arginase-1 and suppress T-cell
functions [105]. Another mechanism by which neutro-
phils might inhibit T-cell responses is through PD-L1
[106]. Neutrophils isolated from sepsis patients expressthe surface protein PD-L1, a potent inducer of apoptosis
in T cells. The underlying mechanism of PD-L1 expres-
sion is an interferon-gamma-dependent process [106].
The PD-1–PD-L1 axis is thought to be an important
mechanism in immune suppression in septic patients
by inducing lymphocyte apoptosis and monocyte dys-
function [107]. Blocking this axis after the induction
of sepsis by administering a PD-1-blocking antibody
improved survival in mice [108]. This suppressive
mechanism might be protective in tissues with severe
inflammatory infiltrates. On the other hand, this
process might be unwanted when neutrophils migrate
to lymph nodes and engage with adaptive immunity,
as has been described under various conditions [109].
In these lymph nodes neutrophils are able to inhibit
humoral immune responses through interaction with
T and B lymphocytes [109, 110].
Conclusion
Severe inflammation can result in immune paralysis
through various mechanisms. We propose that neutro-
phils play a central role in this process, either through
decreased antimicrobial functions or through direct sup-
pression of (adaptive) immunity. Many experimental
studies have been performed addressing the damaging
role of neutrophils, which contributes to organ failure in
severe inflammation. However, their role in immune par-
alysis remains understudied. Studies to explore their
causative role in susceptibility to infections in animal
models of severe inflammation should be designed. De-
creased neutrophil antimicrobial functions and their
ability to suppress adaptive immunity in vitro should be
Leliefeld et al. Critical Care  (2016) 20:73 Page 7 of 9considered as important patient outcomes. This ap-
proach is necessary to increase understanding of the role
of neutrophils in immune paralysis leading to detrimen-
tal outcome in post-surgical, post-trauma and septic
patients.
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